Haemofiltration
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
MediSieveUK - London
2 programs1
MediSieve Magnetic Haemofiltration SystemPhase 11 trial
MediSieve Magnetic Haemofiltration SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MediSieveMediSieve Magnetic Haemofiltration System
MediSieveMediSieve Magnetic Haemofiltration System
Clinical Trials (2)
Total enrollment: 6 patients across 2 trials
Clinical Investigation of the Safety of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers
Start: Jun 2022Est. completion: Nov 20226 patients
Phase 1Completed
Safety and Initial Performance of the MediSieve Magnetic Haemofiltration System
Start: Jun 2020Est. completion: Dec 20200
N/AWithdrawn
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.